Evidence map›Paper›PMID 35625943›Full record

ReviewBiomedicines2022

TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications.

Jian Luo

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jian LuoPalo Alto Veterans Institute for Research, VAPAHCS, Palo Alto, CA 94304, USA.ORCID 0000-0002-2064-8467
VA Palo Alto Health Care System · US

Funding

Targeting Cerebrovascular TGF Signaling in Alzheimer's DiseaseRF1AG059694 · NIA · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI LUO, JIAN, WYSS-CORAY, TONY · 2018 to 2018
$3.0M
TGF-β Signaling as a Novel Therapeutic Target for Mild Traumatic Brain InjuryR01NS092868 · NINDS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI LUO, JIAN · 2016 to 2020
$1.5M
NIA NIH HHS RF1 AG059694NIH HHS R01NS092868, RF1AG059694NINDS NIH HHS R01 NS092868
6 · The paper itself

Abstract

Astrocytes are essential for normal brain development and functioning. They respond to brain injury and disease through a process referred to as reactive astrogliosis, where the reactivity is highly heterogenous and context-dependent. Reactive astrocytes are active contributors to brain pathology and can exert beneficial, detrimental, or mixed effects following brain insults. Transforming growth factor-β (TGF-β) has been identified as one of the key factors regulating astrocyte reactivity. The genetic and pharmacological manipulation of the TGF-β signaling pathway in animal models of central nervous system (CNS) injury and disease alters pathological and functional outcomes. This review aims to provide recent understanding regarding astrocyte reactivity and TGF-β signaling in brain injury, aging, and neurodegeneration. Further, it explores how TGF-β signaling modulates astrocyte reactivity and function in the context of CNS disease and injury.

Indexed as

agingAlzheimer’s diseaseamyotrophic lateral sclerosisastrocytesepilepsymultiple sclerosisParkinson’s diseasereactive astrogliosisstrokeTGF-βtraumatic brain injury

Identifiers

PMID35625943
PMCPMC9138510
OpenAlexW4281400797

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.